MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

March 23, 2018

Khumbulani, 16, has multidrug-resistant tuberculosis (MDR-TB). In 2017, he lost his hearing. In early 2018, his eyesight faded. The side effects were not from the disease, but from Khumbulani's treatment. Better drugs for resistant strains of TB exist, but too few people have access to them. It's time to #StepUpForTB

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

February 27, 2017

FEBRUARY 27, 2017—Thousands of people trying to flee Eritrea are suffering from inhumane, violent, and deadly treatment as the European Union increasingly collaborates with the governments of Eritrea, Libya, Sudan, and Ethiopia to stop them from reaching European shores, according to a new report by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).

October 25, 2016

South Africa has one of the highest burdens of tuberculosis (TB) and drug-resistant tuberculosis (DR-TB) in the world, with more than 20,000 people diagnosed with DR-TB in 2015. Yet the current DR-TB treatment regimen—which consists of a combination of multiple pills and daily injections—is only successful in about half of all people who receive it. New drugs such as delamanid offer the opportunity to provide more successful, tolerable treatment regimens to patients with few other options available.

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

July 22, 2016

"Libya is a very dangerous place. There are a lot of armed people. People are killed and kidnappings are common. Arriving in Tripoli, we were locked in a house with 600 to 700 other people. We had no water to wash ourselves, we had very little food, and we were forced to sleep on top of each other. It was very difficult for my daughter—she fell sick many times. There was a lot of violence. I was beaten with bare hands, with sticks, and with guns. If you move, they beat you. If you talk, they beat you. We spent months like that, being beaten every day."

July 19, 2016

Durban, South Africa—Global HIV/AIDS leaders at the International AIDS Conference in Durban must develop and implement an action plan to address the critical lack of access to HIV treatment in countries in West and Central Africa where coverage remains below 30 percent, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Tuesday.

April 24, 2016

Valletta, Malta, April 24, 2016 — The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) resumed  search, rescue, and medical aid operations in the central Mediterranean Sea, conducting its first operation of 2016 this weekend.

On April 23, the MSF vessel Dignity 1 accepted a transfer of 308 rescued people (205 men, 80 women, 23 children), mainly Eritrean, from an Italian rescue boat. The Dignity 1 is now on its way to Sicily where the 308 people will disembark on Monday.

April 20, 2016

Globally, the years 2000 to 2015 saw the scaling-up of access to antiretroviral therapy (ART), with a 35 percent decrease in AIDS-related deaths since 2005. A record number of almost 16 million people living with HIV (PLHIV) have been initiated on ART as of mid-2015, three in four of whom live in sub-Saharan Africa, where the needs are most acute. Civil society and public health services alike have rallied to bring new evidence-based treatments and best practices to PLHIV.

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

Pages

March 23, 2018

Khumbulani, 16, has multidrug-resistant tuberculosis (MDR-TB). In 2017, he lost his hearing. In early 2018, his eyesight faded. The side effects were not from the disease, but from Khumbulani's treatment. Better drugs for resistant strains of TB exist, but too few people have access to them. It's time to #StepUpForTB

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

February 27, 2017

FEBRUARY 27, 2017—Thousands of people trying to flee Eritrea are suffering from inhumane, violent, and deadly treatment as the European Union increasingly collaborates with the governments of Eritrea, Libya, Sudan, and Ethiopia to stop them from reaching European shores, according to a new report by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).

October 25, 2016

South Africa has one of the highest burdens of tuberculosis (TB) and drug-resistant tuberculosis (DR-TB) in the world, with more than 20,000 people diagnosed with DR-TB in 2015. Yet the current DR-TB treatment regimen—which consists of a combination of multiple pills and daily injections—is only successful in about half of all people who receive it. New drugs such as delamanid offer the opportunity to provide more successful, tolerable treatment regimens to patients with few other options available.

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

July 22, 2016

"Libya is a very dangerous place. There are a lot of armed people. People are killed and kidnappings are common. Arriving in Tripoli, we were locked in a house with 600 to 700 other people. We had no water to wash ourselves, we had very little food, and we were forced to sleep on top of each other. It was very difficult for my daughter—she fell sick many times. There was a lot of violence. I was beaten with bare hands, with sticks, and with guns. If you move, they beat you. If you talk, they beat you. We spent months like that, being beaten every day."

July 19, 2016

Durban, South Africa—Global HIV/AIDS leaders at the International AIDS Conference in Durban must develop and implement an action plan to address the critical lack of access to HIV treatment in countries in West and Central Africa where coverage remains below 30 percent, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Tuesday.

April 24, 2016

Valletta, Malta, April 24, 2016 — The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) resumed  search, rescue, and medical aid operations in the central Mediterranean Sea, conducting its first operation of 2016 this weekend.

On April 23, the MSF vessel Dignity 1 accepted a transfer of 308 rescued people (205 men, 80 women, 23 children), mainly Eritrean, from an Italian rescue boat. The Dignity 1 is now on its way to Sicily where the 308 people will disembark on Monday.

April 20, 2016

Globally, the years 2000 to 2015 saw the scaling-up of access to antiretroviral therapy (ART), with a 35 percent decrease in AIDS-related deaths since 2005. A record number of almost 16 million people living with HIV (PLHIV) have been initiated on ART as of mid-2015, three in four of whom live in sub-Saharan Africa, where the needs are most acute. Civil society and public health services alike have rallied to bring new evidence-based treatments and best practices to PLHIV.

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

Pages